Related Experiment Video

Updated: Aug 27, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Pathogenesis of hypertension in African Americans

Shawna Nesbitt1, Ronald G Victor

  • 1Internal Medicine/Hypertension Division, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

Congestive Heart Failure (Greenwich, Conn.)
|February 12, 2004
PubMed

Insights

Hypertension disproportionately impacts African Americans, increasing cardiovascular risks. Genetic and environmental factors, including epithelial sodium channel gene variations and obesity, contribute to severe outcomes like stroke and kidney disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Genetics

Background:

  • Hypertension is a major risk factor for cardiovascular disease, particularly in African Americans.
  • African Americans experience more severe end-organ damage from hypertension, including stroke, renal disease, and heart failure.

Purpose of the Study:

  • To explore the multifactorial causes of aggressive hypertension in African Americans.
  • To investigate the role of genetic and environmental factors in hypertension outcomes.

Main Methods:

  • Review of existing literature on hypertension in African Americans.
  • Analysis of genetic polymorphisms, specifically epithelial sodium channel (ENaC) variations.
  • Examination of environmental factors such as obesity and sympathetic nervous system activity.

Main Results:

  • Higher rates of stroke, end-stage renal disease, left ventricular hypertrophy, and heart failure observed in African Americans with hypertension.
  • Epithelial sodium channel gene polymorphisms show correlation with hypertension patterns in this demographic.
  • Obesity, particularly in African-American women, is linked to hypertension via sympathetic nervous system stimulation.

Conclusions:

  • Hypertension in African Americans is multifactorial, involving genetic predispositions and environmental influences.
  • ENaC gene variations and obesity are significant contributors to the heightened cardiovascular and renal risks.
  • Further research into these factors is crucial for targeted prevention and treatment strategies.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...